The President of the American Society of Nephrology (ASN), Dr. Thomas DuBose, cited three Welch Center studies in his presidential address to the society at the ASN annual meeting in San Diego in November. The talk was titled: “Translating Scientific and Technological Advances: Progress and Promise for Treating Kidney Disease.” He used the studies, respectively, to illustrate: 1) lessons from international comparisons of chronic kidney disease (CKD) and end-stage renal disease (ESRD) prevalence; 2) the need to view CKD as a public health threat; and 3) his belief that CKD is not being recognized or treated by primary care providers. Abstracts for each study are linked below:
International Comparison of the Relationship of Chronic Kidney Disease Prevalence and ESRD Risk, by Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, Hallan HA, Lydersen S, Holmen J.
Identification and Referral of Patients with Progressive CKD: A National Study, by Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR.
The Timing of Specialist Evaluation in Chronic Kidney Disease and Mortality, by Kinchen KS, Sadler J, Fink N, Brookmeyer R, Klag MJ, Levey AS, Powe NR.